Global Histopathology Services Market

Histopathology Services Comprehensive Study by Examination (Surgical Specimen, Breast Biopsy, Gastrointestinal Biopsy, Testicular Biopsy, Lung Biopsy, Renal Biopsy, Biopsy of Gynecological Cancers, Liver Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Nerve Biopsy, Others), End User (Pharmaceutical, Biotechnology Companies, CROs, Hospitals & Reference Laboratories, Academic & Government Research Institutes) Players and Region - Global Market Outlook to 2030

Histopathology Services Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Histopathology Services
Histopathology is the diagnosis and study of diseases of the tissues and involves examining tissues and/or cells under a microscope. Histopathology services are utilized for preliminary diagnosis of medical indications in clinical settings. Histopathologists are responsible for making tissue diagnoses and helping clinicians manage a patient's care. It plays important role in clinical studies to determine the efficacy, pharmacology, and toxicology of the medical interventions. Histopathology services used for the evaluation of implanted medical devices to understand the structural functions of the implants. Implants include bone plates, artificial cartilages, hip & knee prosthesis, fusion polymers, stents, and others.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United Kingdom Players will contribute the maximum growth to Global Histopathology Services market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Acculabs Diagnostics UK Ltd. (United Kingdom), Great Ormond Street Hospital (GOSH) Laboratory (England), Laboratoire Cerba (France), Spire Healthcare Group plc (United Kingdom), TPL Path Labs (Germany), Targos Molecular Pathology GmbH (Germany), Cellular Pathology Services Limited (United Kingdom), HCA Laboratories UK (United Kingdom), Sonic Healthcare Limited (Australia) and Unilabs Group Services (Switzerland) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Histopathology Services market by and Region.



On the basis of geography, the market of Histopathology Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Examination, the sub-segment i.e. Surgical Specimen will boost the Histopathology Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pharmaceutical will boost the Histopathology Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growth in Technologies related to Histopathology Diagnosis

Market Growth Drivers:
Increase in Prevalence of Such Chronic Conditions and Rise in Health Care Expenditure

Challenges:
Dearth of Skilled Personnel

Restraints:
Lack of Reimbursement

Opportunities:
Increase in the Number of such Fatal Medical Conditions and Changing Healthcare Environment in Developed Economies

Market Leaders and their expansionary development strategies
In September 2023, bioAffinity Technologies Acquired Laboratory Assets of Precision Pathology Services. The acquisition of our partner laboratory Precision Pathology supports and enhances bioAffinity’s commercial strategy by integrating every aspect of
In May 2019, Royal Philips announced that Alverno will fully implement digital pathology in its clinical laboratories. The laboratory network will use Philips IntelliSite Pathology Solution to assess and diagnose all clinical histology cases digitally, instead of using a microscope, with the aim of improving laboratory efficiency, quality, and patient safety.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Histopathology Services Provider, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Examination
  • Surgical Specimen
  • Breast Biopsy
  • Gastrointestinal Biopsy
  • Testicular Biopsy
  • Lung Biopsy
  • Renal Biopsy
  • Biopsy of Gynecological Cancers
  • Liver Biopsy
  • Pancreatic Biopsy
  • Skin Tissue Biopsy
  • Nerve Biopsy
  • Others

By End User
  • Pharmaceutical
  • Biotechnology Companies
  • CROs
  • Hospitals & Reference Laboratories
  • Academic & Government Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Prevalence of Such Chronic Conditions
      • 3.2.2. Rise in Health Care Expenditure
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Personnel
    • 3.4. Market Trends
      • 3.4.1. Growth in Technologies related to Histopathology Diagnosis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Histopathology Services, by Examination, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Histopathology Services (Value)
      • 5.2.1. Global Histopathology Services by: Examination (Value)
        • 5.2.1.1. Surgical Specimen
        • 5.2.1.2. Breast Biopsy
        • 5.2.1.3. Gastrointestinal Biopsy
        • 5.2.1.4. Testicular Biopsy
        • 5.2.1.5. Lung Biopsy
        • 5.2.1.6. Renal Biopsy
        • 5.2.1.7. Biopsy of Gynecological Cancers
        • 5.2.1.8. Liver Biopsy
        • 5.2.1.9. Pancreatic Biopsy
        • 5.2.1.10. Skin Tissue Biopsy
        • 5.2.1.11. Nerve Biopsy
        • 5.2.1.12. Others
      • 5.2.2. Global Histopathology Services by: End User (Value)
        • 5.2.2.1. Pharmaceutical
        • 5.2.2.2. Biotechnology Companies
        • 5.2.2.3. CROs
        • 5.2.2.4. Hospitals & Reference Laboratories
        • 5.2.2.5. Academic & Government Research Institutes
      • 5.2.3. Global Histopathology Services Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Histopathology Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Acculabs Diagnostics UK Ltd. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Great Ormond Street Hospital (GOSH) Laboratory (England)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Laboratoire Cerba (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Spire Healthcare Group plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. TPL Path Labs (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Targos Molecular Pathology GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cellular Pathology Services Limited (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. HCA Laboratories UK (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sonic Healthcare Limited (Australia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Unilabs Group Services (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Histopathology Services Sale, by Examination, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Histopathology Services (Value)
      • 7.2.1. Global Histopathology Services by: Examination (Value)
        • 7.2.1.1. Surgical Specimen
        • 7.2.1.2. Breast Biopsy
        • 7.2.1.3. Gastrointestinal Biopsy
        • 7.2.1.4. Testicular Biopsy
        • 7.2.1.5. Lung Biopsy
        • 7.2.1.6. Renal Biopsy
        • 7.2.1.7. Biopsy of Gynecological Cancers
        • 7.2.1.8. Liver Biopsy
        • 7.2.1.9. Pancreatic Biopsy
        • 7.2.1.10. Skin Tissue Biopsy
        • 7.2.1.11. Nerve Biopsy
        • 7.2.1.12. Others
      • 7.2.2. Global Histopathology Services by: End User (Value)
        • 7.2.2.1. Pharmaceutical
        • 7.2.2.2. Biotechnology Companies
        • 7.2.2.3. CROs
        • 7.2.2.4. Hospitals & Reference Laboratories
        • 7.2.2.5. Academic & Government Research Institutes
      • 7.2.3. Global Histopathology Services Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Histopathology Services: by Examination(USD Million)
  • Table 2. Histopathology Services Surgical Specimen , by Region USD Million (2018-2023)
  • Table 3. Histopathology Services Breast Biopsy , by Region USD Million (2018-2023)
  • Table 4. Histopathology Services Gastrointestinal Biopsy , by Region USD Million (2018-2023)
  • Table 5. Histopathology Services Testicular Biopsy , by Region USD Million (2018-2023)
  • Table 6. Histopathology Services Lung Biopsy , by Region USD Million (2018-2023)
  • Table 7. Histopathology Services Renal Biopsy , by Region USD Million (2018-2023)
  • Table 8. Histopathology Services Biopsy of Gynecological Cancers , by Region USD Million (2018-2023)
  • Table 9. Histopathology Services Liver Biopsy , by Region USD Million (2018-2023)
  • Table 10. Histopathology Services Pancreatic Biopsy , by Region USD Million (2018-2023)
  • Table 11. Histopathology Services Skin Tissue Biopsy , by Region USD Million (2018-2023)
  • Table 12. Histopathology Services Nerve Biopsy , by Region USD Million (2018-2023)
  • Table 13. Histopathology Services Others , by Region USD Million (2018-2023)
  • Table 14. Histopathology Services: by End User(USD Million)
  • Table 15. Histopathology Services Pharmaceutical , by Region USD Million (2018-2023)
  • Table 16. Histopathology Services Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 17. Histopathology Services CROs , by Region USD Million (2018-2023)
  • Table 18. Histopathology Services Hospitals & Reference Laboratories , by Region USD Million (2018-2023)
  • Table 19. Histopathology Services Academic & Government Research Institutes , by Region USD Million (2018-2023)
  • Table 20. South America Histopathology Services, by Country USD Million (2018-2023)
  • Table 21. South America Histopathology Services, by Examination USD Million (2018-2023)
  • Table 22. South America Histopathology Services, by End User USD Million (2018-2023)
  • Table 23. Brazil Histopathology Services, by Examination USD Million (2018-2023)
  • Table 24. Brazil Histopathology Services, by End User USD Million (2018-2023)
  • Table 25. Argentina Histopathology Services, by Examination USD Million (2018-2023)
  • Table 26. Argentina Histopathology Services, by End User USD Million (2018-2023)
  • Table 27. Rest of South America Histopathology Services, by Examination USD Million (2018-2023)
  • Table 28. Rest of South America Histopathology Services, by End User USD Million (2018-2023)
  • Table 29. Asia Pacific Histopathology Services, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific Histopathology Services, by Examination USD Million (2018-2023)
  • Table 31. Asia Pacific Histopathology Services, by End User USD Million (2018-2023)
  • Table 32. China Histopathology Services, by Examination USD Million (2018-2023)
  • Table 33. China Histopathology Services, by End User USD Million (2018-2023)
  • Table 34. Japan Histopathology Services, by Examination USD Million (2018-2023)
  • Table 35. Japan Histopathology Services, by End User USD Million (2018-2023)
  • Table 36. India Histopathology Services, by Examination USD Million (2018-2023)
  • Table 37. India Histopathology Services, by End User USD Million (2018-2023)
  • Table 38. South Korea Histopathology Services, by Examination USD Million (2018-2023)
  • Table 39. South Korea Histopathology Services, by End User USD Million (2018-2023)
  • Table 40. Taiwan Histopathology Services, by Examination USD Million (2018-2023)
  • Table 41. Taiwan Histopathology Services, by End User USD Million (2018-2023)
  • Table 42. Australia Histopathology Services, by Examination USD Million (2018-2023)
  • Table 43. Australia Histopathology Services, by End User USD Million (2018-2023)
  • Table 44. Rest of Asia-Pacific Histopathology Services, by Examination USD Million (2018-2023)
  • Table 45. Rest of Asia-Pacific Histopathology Services, by End User USD Million (2018-2023)
  • Table 46. Europe Histopathology Services, by Country USD Million (2018-2023)
  • Table 47. Europe Histopathology Services, by Examination USD Million (2018-2023)
  • Table 48. Europe Histopathology Services, by End User USD Million (2018-2023)
  • Table 49. Germany Histopathology Services, by Examination USD Million (2018-2023)
  • Table 50. Germany Histopathology Services, by End User USD Million (2018-2023)
  • Table 51. France Histopathology Services, by Examination USD Million (2018-2023)
  • Table 52. France Histopathology Services, by End User USD Million (2018-2023)
  • Table 53. Italy Histopathology Services, by Examination USD Million (2018-2023)
  • Table 54. Italy Histopathology Services, by End User USD Million (2018-2023)
  • Table 55. United Kingdom Histopathology Services, by Examination USD Million (2018-2023)
  • Table 56. United Kingdom Histopathology Services, by End User USD Million (2018-2023)
  • Table 57. Netherlands Histopathology Services, by Examination USD Million (2018-2023)
  • Table 58. Netherlands Histopathology Services, by End User USD Million (2018-2023)
  • Table 59. Rest of Europe Histopathology Services, by Examination USD Million (2018-2023)
  • Table 60. Rest of Europe Histopathology Services, by End User USD Million (2018-2023)
  • Table 61. MEA Histopathology Services, by Country USD Million (2018-2023)
  • Table 62. MEA Histopathology Services, by Examination USD Million (2018-2023)
  • Table 63. MEA Histopathology Services, by End User USD Million (2018-2023)
  • Table 64. Middle East Histopathology Services, by Examination USD Million (2018-2023)
  • Table 65. Middle East Histopathology Services, by End User USD Million (2018-2023)
  • Table 66. Africa Histopathology Services, by Examination USD Million (2018-2023)
  • Table 67. Africa Histopathology Services, by End User USD Million (2018-2023)
  • Table 68. North America Histopathology Services, by Country USD Million (2018-2023)
  • Table 69. North America Histopathology Services, by Examination USD Million (2018-2023)
  • Table 70. North America Histopathology Services, by End User USD Million (2018-2023)
  • Table 71. United States Histopathology Services, by Examination USD Million (2018-2023)
  • Table 72. United States Histopathology Services, by End User USD Million (2018-2023)
  • Table 73. Canada Histopathology Services, by Examination USD Million (2018-2023)
  • Table 74. Canada Histopathology Services, by End User USD Million (2018-2023)
  • Table 75. Mexico Histopathology Services, by Examination USD Million (2018-2023)
  • Table 76. Mexico Histopathology Services, by End User USD Million (2018-2023)
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Company Basic Information, Sales Area and Its Competitors
  • Table 86. Company Basic Information, Sales Area and Its Competitors
  • Table 87. Histopathology Services: by Examination(USD Million)
  • Table 88. Histopathology Services Surgical Specimen , by Region USD Million (2025-2030)
  • Table 89. Histopathology Services Breast Biopsy , by Region USD Million (2025-2030)
  • Table 90. Histopathology Services Gastrointestinal Biopsy , by Region USD Million (2025-2030)
  • Table 91. Histopathology Services Testicular Biopsy , by Region USD Million (2025-2030)
  • Table 92. Histopathology Services Lung Biopsy , by Region USD Million (2025-2030)
  • Table 93. Histopathology Services Renal Biopsy , by Region USD Million (2025-2030)
  • Table 94. Histopathology Services Biopsy of Gynecological Cancers , by Region USD Million (2025-2030)
  • Table 95. Histopathology Services Liver Biopsy , by Region USD Million (2025-2030)
  • Table 96. Histopathology Services Pancreatic Biopsy , by Region USD Million (2025-2030)
  • Table 97. Histopathology Services Skin Tissue Biopsy , by Region USD Million (2025-2030)
  • Table 98. Histopathology Services Nerve Biopsy , by Region USD Million (2025-2030)
  • Table 99. Histopathology Services Others , by Region USD Million (2025-2030)
  • Table 100. Histopathology Services: by End User(USD Million)
  • Table 101. Histopathology Services Pharmaceutical , by Region USD Million (2025-2030)
  • Table 102. Histopathology Services Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 103. Histopathology Services CROs , by Region USD Million (2025-2030)
  • Table 104. Histopathology Services Hospitals & Reference Laboratories , by Region USD Million (2025-2030)
  • Table 105. Histopathology Services Academic & Government Research Institutes , by Region USD Million (2025-2030)
  • Table 106. South America Histopathology Services, by Country USD Million (2025-2030)
  • Table 107. South America Histopathology Services, by Examination USD Million (2025-2030)
  • Table 108. South America Histopathology Services, by End User USD Million (2025-2030)
  • Table 109. Brazil Histopathology Services, by Examination USD Million (2025-2030)
  • Table 110. Brazil Histopathology Services, by End User USD Million (2025-2030)
  • Table 111. Argentina Histopathology Services, by Examination USD Million (2025-2030)
  • Table 112. Argentina Histopathology Services, by End User USD Million (2025-2030)
  • Table 113. Rest of South America Histopathology Services, by Examination USD Million (2025-2030)
  • Table 114. Rest of South America Histopathology Services, by End User USD Million (2025-2030)
  • Table 115. Asia Pacific Histopathology Services, by Country USD Million (2025-2030)
  • Table 116. Asia Pacific Histopathology Services, by Examination USD Million (2025-2030)
  • Table 117. Asia Pacific Histopathology Services, by End User USD Million (2025-2030)
  • Table 118. China Histopathology Services, by Examination USD Million (2025-2030)
  • Table 119. China Histopathology Services, by End User USD Million (2025-2030)
  • Table 120. Japan Histopathology Services, by Examination USD Million (2025-2030)
  • Table 121. Japan Histopathology Services, by End User USD Million (2025-2030)
  • Table 122. India Histopathology Services, by Examination USD Million (2025-2030)
  • Table 123. India Histopathology Services, by End User USD Million (2025-2030)
  • Table 124. South Korea Histopathology Services, by Examination USD Million (2025-2030)
  • Table 125. South Korea Histopathology Services, by End User USD Million (2025-2030)
  • Table 126. Taiwan Histopathology Services, by Examination USD Million (2025-2030)
  • Table 127. Taiwan Histopathology Services, by End User USD Million (2025-2030)
  • Table 128. Australia Histopathology Services, by Examination USD Million (2025-2030)
  • Table 129. Australia Histopathology Services, by End User USD Million (2025-2030)
  • Table 130. Rest of Asia-Pacific Histopathology Services, by Examination USD Million (2025-2030)
  • Table 131. Rest of Asia-Pacific Histopathology Services, by End User USD Million (2025-2030)
  • Table 132. Europe Histopathology Services, by Country USD Million (2025-2030)
  • Table 133. Europe Histopathology Services, by Examination USD Million (2025-2030)
  • Table 134. Europe Histopathology Services, by End User USD Million (2025-2030)
  • Table 135. Germany Histopathology Services, by Examination USD Million (2025-2030)
  • Table 136. Germany Histopathology Services, by End User USD Million (2025-2030)
  • Table 137. France Histopathology Services, by Examination USD Million (2025-2030)
  • Table 138. France Histopathology Services, by End User USD Million (2025-2030)
  • Table 139. Italy Histopathology Services, by Examination USD Million (2025-2030)
  • Table 140. Italy Histopathology Services, by End User USD Million (2025-2030)
  • Table 141. United Kingdom Histopathology Services, by Examination USD Million (2025-2030)
  • Table 142. United Kingdom Histopathology Services, by End User USD Million (2025-2030)
  • Table 143. Netherlands Histopathology Services, by Examination USD Million (2025-2030)
  • Table 144. Netherlands Histopathology Services, by End User USD Million (2025-2030)
  • Table 145. Rest of Europe Histopathology Services, by Examination USD Million (2025-2030)
  • Table 146. Rest of Europe Histopathology Services, by End User USD Million (2025-2030)
  • Table 147. MEA Histopathology Services, by Country USD Million (2025-2030)
  • Table 148. MEA Histopathology Services, by Examination USD Million (2025-2030)
  • Table 149. MEA Histopathology Services, by End User USD Million (2025-2030)
  • Table 150. Middle East Histopathology Services, by Examination USD Million (2025-2030)
  • Table 151. Middle East Histopathology Services, by End User USD Million (2025-2030)
  • Table 152. Africa Histopathology Services, by Examination USD Million (2025-2030)
  • Table 153. Africa Histopathology Services, by End User USD Million (2025-2030)
  • Table 154. North America Histopathology Services, by Country USD Million (2025-2030)
  • Table 155. North America Histopathology Services, by Examination USD Million (2025-2030)
  • Table 156. North America Histopathology Services, by End User USD Million (2025-2030)
  • Table 157. United States Histopathology Services, by Examination USD Million (2025-2030)
  • Table 158. United States Histopathology Services, by End User USD Million (2025-2030)
  • Table 159. Canada Histopathology Services, by Examination USD Million (2025-2030)
  • Table 160. Canada Histopathology Services, by End User USD Million (2025-2030)
  • Table 161. Mexico Histopathology Services, by Examination USD Million (2025-2030)
  • Table 162. Mexico Histopathology Services, by End User USD Million (2025-2030)
  • Table 163. Research Programs/Design for This Report
  • Table 164. Key Data Information from Secondary Sources
  • Table 165. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Histopathology Services: by Examination USD Million (2018-2023)
  • Figure 5. Global Histopathology Services: by End User USD Million (2018-2023)
  • Figure 6. South America Histopathology Services Share (%), by Country
  • Figure 7. Asia Pacific Histopathology Services Share (%), by Country
  • Figure 8. Europe Histopathology Services Share (%), by Country
  • Figure 9. MEA Histopathology Services Share (%), by Country
  • Figure 10. North America Histopathology Services Share (%), by Country
  • Figure 11. Global Histopathology Services share by Players 2023 (%)
  • Figure 12. Global Histopathology Services share by Players (Top 3) 2023(%)
  • Figure 13. Global Histopathology Services share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Acculabs Diagnostics UK Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 16. Acculabs Diagnostics UK Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 17. Great Ormond Street Hospital (GOSH) Laboratory (England) Revenue, Net Income and Gross profit
  • Figure 18. Great Ormond Street Hospital (GOSH) Laboratory (England) Revenue: by Geography 2023
  • Figure 19. Laboratoire Cerba (France) Revenue, Net Income and Gross profit
  • Figure 20. Laboratoire Cerba (France) Revenue: by Geography 2023
  • Figure 21. Spire Healthcare Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Spire Healthcare Group plc (United Kingdom) Revenue: by Geography 2023
  • Figure 23. TPL Path Labs (Germany) Revenue, Net Income and Gross profit
  • Figure 24. TPL Path Labs (Germany) Revenue: by Geography 2023
  • Figure 25. Targos Molecular Pathology GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Targos Molecular Pathology GmbH (Germany) Revenue: by Geography 2023
  • Figure 27. Cellular Pathology Services Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Cellular Pathology Services Limited (United Kingdom) Revenue: by Geography 2023
  • Figure 29. HCA Laboratories UK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. HCA Laboratories UK (United Kingdom) Revenue: by Geography 2023
  • Figure 31. Sonic Healthcare Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 32. Sonic Healthcare Limited (Australia) Revenue: by Geography 2023
  • Figure 33. Unilabs Group Services (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Unilabs Group Services (Switzerland) Revenue: by Geography 2023
  • Figure 35. Global Histopathology Services: by Examination USD Million (2025-2030)
  • Figure 36. Global Histopathology Services: by End User USD Million (2025-2030)
  • Figure 37. South America Histopathology Services Share (%), by Country
  • Figure 38. Asia Pacific Histopathology Services Share (%), by Country
  • Figure 39. Europe Histopathology Services Share (%), by Country
  • Figure 40. MEA Histopathology Services Share (%), by Country
  • Figure 41. North America Histopathology Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Acculabs Diagnostics UK Ltd. (United Kingdom)
  • Great Ormond Street Hospital (GOSH) Laboratory (England)
  • Laboratoire Cerba (France)
  • Spire Healthcare Group plc (United Kingdom)
  • TPL Path Labs (Germany)
  • Targos Molecular Pathology GmbH (Germany)
  • Cellular Pathology Services Limited (United Kingdom)
  • HCA Laboratories UK (United Kingdom)
  • Sonic Healthcare Limited (Australia)
  • Unilabs Group Services (Switzerland)
Select User Access Type

Key Highlights of Report


Mar 2024 217 Pages 81 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Histopathology Services Market Quantitative research analysis
Global Histopathology Services Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Acculabs Diagnostics UK Ltd. (United Kingdom), Great Ormond Street Hospital (GOSH) Laboratory (England), Laboratoire Cerba (France), Spire Healthcare Group plc (United Kingdom), TPL Path Labs (Germany), Targos Molecular Pathology GmbH (Germany), Cellular Pathology Services Limited (United Kingdom), HCA Laboratories UK (United Kingdom), Sonic Healthcare Limited (Australia) and Unilabs Group Services (Switzerland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growth in Technologies related to Histopathology Diagnosis" is seen as one of major influencing trends for Histopathology Services Market during projected period 2023-2030.
The Histopathology Services market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Histopathology Services Market Report?

Have a Query? Click Here

Other Related Reports

Vaccine Storage & Packaging Comprehensive Study by Type (Vaccine Storage, Vaccine Packaging), Vaccine Packaging (Packaging (Vaccine Cool Bags, Vials, and Ampoules, Corrugated Boxes, Others), Packagin...
$ 3750
Animal Treatment Comprehensive Study by Type (Pharmaceuticals, Feed Additives), Application (Laboratory Services, Animal Emergency Care, Pain Management, Animal Specialty Services, Vitamins and Suppl...
$ 3650
Lymphedema Diagnostics Comprehensive Study by Application (Lymphedema Surgery Center, Hospitals, Clinics), Diagnostic Tests (MRI Scan, CT Scan, Doppler Ultrasound, Lymphoscintigraphy), Disease Type (...
$ 3750
Veterinary Care Comprehensive Study by Type (Therapeutics (Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives, Others), Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagn...
$ 3750
Elastography Imaging Comprehensive Study by Application (Cardiology, OB/GYN, Urology, Vascular, Radiology/General Imaging, Orthopedic and Musculoskeletal Applications, Others), Modality (Ultrasound E...
$ 3650
Private Nursing Services Comprehensive Study by Type (Critical Care Nursing, Tracheostomy Nursing, Palliative Nursing, Mother & Babycare Nursing, Travel Abroad Nursing, Palliative Nursing, Geriatric ...
$ 3650